City
Epaper

Signity Pharmaceuticals bags title of 'The Fastest Growing Pharmaceutical Company of Central India'

By ANI | Updated: January 7, 2022 18:25 IST

Signity Pharmaceuticals Pvt. Ltd., an upcoming super-specialty company, has been honoured with the title of "The Fastest Growing Pharmaceutical Company of Central India" at the International Business Leadership Awards 2021.

Open in App

Pvt. Ltd., an upcoming super-specialty company, has been honoured with the title of "The Fastest Growing Pharmaceutical Company of Central India" at the International Business Leadership Awards 2021.

The award ceremony was organized at Hotel Novotel, Goa on December 23, 2021 by Faggan Singh Kulaste- the Minister Rural Development and Minister of Steel, Government of India, Pandit Sunil Bharala- the Chairman/ Minister of State, Labour Welfare Council, Government of Uttar Pradesh and famous Bollywood Actress- Poonam Dhillon.

India's drugs and pharmaceuticals exports stood at US$ 24.44 billion in FY21 making it the 12th largest exporter of medical goods in the world. In this scenario, Signity Pharmaceuticals is striving to emerge as a leading exporter of nutraceutical products. They have already earned a big reputation in exporting high-quality nutraceutical products to Europe, America & South East Asian Markets. Now, they are looking forward to pushing their R&D efforts further to establish their authority in the global pharmaceutical market. They have also introduced the India's first-of-its-kind liver preparation. Signity has also applied for its patent.

On this occasion, company's director Shridhar Dhavle said, "It has been a great journey for us. We have started our journey with a vision of introducing innovative drug formulations as an aid to the country's healthcare system. Our unique nutraceutical formulations have already gained acknowledgment across the country. We express our deep gratitude to the medical fraternity and all our well-wishers for their wholehearted support and confidence in us which always inspired us to excel and grow during the last 11 years."

Under the leadership of Bhupendra Marliwar along with Shridhar Dhavle & Vishal Mulani, Signity is all ready to cater to the needs of the existing medical infrastructure with novel and world-class drug formulations. Signity Pharmaceuticals offer a myriad range of industry-leading products like anti-infectives, life-saving drugs, hepatoprotective drugs, immunomodulators, neurotropics, advanced pain management drugs, nutraceutical formulations and respiratory formulations to continuously revolutionize the sector.

This story is provided by TPT.will not be responsible in any way for the content of this article. (ANI/TPT)

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: goaindiaPvt. ltd.StateShridhar dhavle
Open in App

Related Stories

InternationalWhen Will Russia Deliver More S-400 Missiles to India? Major Update Revealed - Here’s Why It Was Delayed

MaharashtraNagpur-Goa Shaktipeeth Expressway: Joint Survey Completed in 92 Villages; Land Acquisition to Begin Soon

NationalIndia Extends Airspace Ban on Pakistan-Based Aircraft Till July 24

MumbaiWhy Are Over 100 Vande Bharat Trains Being Cancelled Between Mumbai and Goa?

NationalOperation Sindhu: “We Saw Drones, Missiles,” Say Evacuated Students Recounting Life in Iran’s Warzone

Business Realted Stories

BusinessAutomation Anywhere Named a Leader in the 2025 Gartner® Magic Quadrant™ for Robotic Process Automation

BusinessDr. Virendra Kumar, Union Cabinet Minister (MoSJE), inaugurated 3rd Trans Employment Mela 2025; over 160 candidates, rising corporate support

BusinessIndia Tops Global Confidence at 93%, Yet Job Satisfaction Trails at 65% says ManpowerGroup Talent Barometer Report 2025

BusinessQCOs benefit MSMEs by enhancing product quality, consumer satisfaction: Piyush Goyal

BusinessStock market opens higher as Trump indicates ‘great’ trade deal with India